These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 7836747

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Stimulation of murine natural killer (NK) cells by a monoclonal antibody specific for the NK1.1 antigen. IL-2-activated NK cells possess additional specific stimulation pathways.
    Karlhofer FM, Yokoyama WM.
    J Immunol; 1991 May 15; 146(10):3662-73. PubMed ID: 2026886
    [Abstract] [Full Text] [Related]

  • 3. Lymphokine-activated killer cells. VII. IL-4 induces an NK1.1+CD8 alpha+beta- TCR-alpha beta B220+ lymphokine-activated killer subset.
    Ballas ZK, Rasmussen W.
    J Immunol; 1993 Jan 01; 150(1):17-30. PubMed ID: 7678028
    [Abstract] [Full Text] [Related]

  • 4. In vivo activation of natural killer cells and priming of IL-2 responsive cytolytic cells by loxoribine (7-allyl-8-oxoguanosine).
    Pope BL, Chourmouzis E, Sigindere J, MacIntyre JP, Capetola RJ, Lau CY.
    Cell Immunol; 1993 Apr 01; 147(2):302-12. PubMed ID: 8453674
    [Abstract] [Full Text] [Related]

  • 5. NK1.1 cells express 4-1BB (CDw137) costimulatory molecule and are required for tumor immunity elicited by anti-4-1BB monoclonal antibodies.
    Melero I, Johnston JV, Shufford WW, Mittler RS, Chen L.
    Cell Immunol; 1998 Dec 15; 190(2):167-72. PubMed ID: 9878117
    [Abstract] [Full Text] [Related]

  • 6. Lymphokine-activated killer (LAK) cells. IV. Characterization of murine LAK effector subpopulations.
    Ballas ZK, Rasmussen W.
    J Immunol; 1990 Jan 01; 144(1):386-95. PubMed ID: 2104892
    [Abstract] [Full Text] [Related]

  • 7. Characterization of four new monoclonal antibodies that recognize mouse natural killer activation receptors.
    Kung SK, Su RC, Shannon J, Miller RG.
    Hybridoma; 2001 Apr 01; 20(2):91-101. PubMed ID: 11394535
    [Abstract] [Full Text] [Related]

  • 8. Gamma delta T cells in the pathobiology of murine acute graft-versus-host disease. Evidence that gamma delta T cells mediate natural killer-like cytotoxicity in the host and that elimination of these cells from donors significantly reduces mortality.
    Ellison CA, MacDonald GC, Rector ES, Gartner JG.
    J Immunol; 1995 Nov 01; 155(9):4189-98. PubMed ID: 7594574
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Natural killer cell depletion fails to influence initial CD4 T cell commitment in vivo in exogenous antigen-stimulated cytokine and antibody responses.
    Wang M, Ellison CA, Gartner JG, HayGlass KT.
    J Immunol; 1998 Feb 01; 160(3):1098-105. PubMed ID: 9570522
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW, Shamim F, Hamon M, Macdonald ID, Prentice HG.
    Exp Hematol; 1995 Dec 01; 23(14):1530-4. PubMed ID: 8542943
    [Abstract] [Full Text] [Related]

  • 14. Use of lymphokine-activated killer cells to prevent bone marrow graft rejection and lethal graft-vs-host disease.
    Azuma E, Yamamoto H, Kaplan J.
    J Immunol; 1989 Sep 01; 143(5):1524-9. PubMed ID: 2668409
    [Abstract] [Full Text] [Related]

  • 15. Mouse natural killer subsets defined by their target specificity and their ability to be separately rendered unresponsive in vivo.
    Kung SK, Miller RG.
    J Immunol; 1997 Mar 15; 158(6):2616-26. PubMed ID: 9058794
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Resistance to malarial infection is achieved by the cooperation of NK1.1(+) and NK1.1(-) subsets of intermediate TCR cells which are constituents of innate immunity.
    Mannoor MK, Weerasinghe A, Halder RC, Reza S, Morshed M, Ariyasinghe A, Watanabe H, Sekikawa H, Abo T.
    Cell Immunol; 2001 Aug 01; 211(2):96-104. PubMed ID: 11591113
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.